Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Scirhom GmbH has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single matter is assigned to 1 distinct examiner within the art unit. Elizabeth A. Shupe is the busiest examiner for the portfolio, responsible for the pending office action currently on record.
The concentration of the portfolio under a specific examiner and art unit reflects a focused prosecution environment. Because there is a pending office action, the company's immediate patent strategy in the biotechnology sector depends entirely on the review process of Elizabeth A. Shupe.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHUPE, ELIZABETH A | 1 | 65.8% | +45.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17602183 | PROTEIN BINDERS FOR IRHOM2 | SHUPE, ELIZABETH A | — |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17602183 | PROTEIN BINDERS FOR IRHOM2 | SHUPE, ELIZABETH A | 1643 | §112DP | Non-Final OA | — | Pending | Oct 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialScirhom GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Elizabeth A Shupe has the most, with 1 of Scirhom GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
